Structure-based discovery of antiviral inhibitors targeting the E dimer interface of Japanese encephalitis virus.
Amino Acid Sequence
Animals
Antiviral Agents
/ chemistry
Binding Sites
/ genetics
Databases, Pharmaceutical
Disease Models, Animal
Drug Design
Drug Evaluation, Preclinical
Encephalitis Virus, Japanese
/ chemistry
Encephalitis, Japanese
/ drug therapy
Female
Humans
Mice
Mice, Inbred BALB C
Molecular Docking Simulation
Protein Multimerization
/ drug effects
Protein Structure, Quaternary
/ drug effects
Structure-Activity Relationship
User-Computer Interface
Viral Envelope Proteins
/ chemistry
Antivirus
E dimer
JEV
Virtual screening
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
23 07 2019
23 07 2019
Historique:
received:
19
05
2019
accepted:
24
05
2019
pubmed:
4
6
2019
medline:
7
7
2020
entrez:
4
6
2019
Statut:
ppublish
Résumé
Flaviviruses are emerging arthropod-borne viruses posing a great threat to human beings worldwide. The E dimer configuration of the flavivirus was prominent during viral assembly, maturation and entry. Neutralization antibodies targeting E dimer played the important role in controlling the flavivirus infection. Previously, the ideal drug target of small molecular inhibitors of JEV was viral proteases and polymerases. The crystal structure of JEV E protein showed a conserved pocket in it is important at membrane fusion step. Recently, a set of anti-virus drugs has been found by virtual screening. Here, we show that the fusion-loop pocket of JEV E protein was a conservative region and an ideal drug target. ChemDiv-3 from virtual screening as the lead compound was found to show a relatively modest inhibition effect for JEV in vitro and in vivo test and could interfere with the formation of JEV sE dimer. ChemDiv-3 interacts with the amino acid residues ASN 313, PRO 314, ALA 315, and VAL 323 in E protein via hydrogen bonds for occupation of the fusion-loop pocket. The key binding sites LYS 312, ALA 513 and THR 317 forming the fusion-loop pocket are the same and other auxiliary sites are similar among the flavivirus. Taken together, the fusion-loop pocket of the flavivirus could be one promising target for drug discovery.
Identifiants
pubmed: 31155294
pii: S0006-291X(19)31044-7
doi: 10.1016/j.bbrc.2019.05.148
pii:
doi:
Substances chimiques
Antiviral Agents
0
Viral Envelope Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
366-371Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.